XORTX Therapeutics, Inc. (XRTX)
1.06
0.00 (0.00%)
USD |
NASDAQ |
Oct 27, 16:00
1.06
0.00 (0.00%)
After-Hours: 20:00
XORTX Therapeutics Free Cash Flow : -5.239M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.239M |
| March 31, 2026 | -2.688M |
| December 31, 2025 | -2.830M |
| September 30, 2025 | -2.952M |
| June 30, 2025 | -3.083M |
| March 31, 2025 | -2.991M |
| December 31, 2024 | -3.651M |
| September 30, 2024 | -4.135M |
| June 30, 2024 | -4.443M |
| March 31, 2024 | -5.430M |
| December 31, 2023 | -6.628M |
| September 30, 2023 | -9.135M |
| June 30, 2023 | -9.009M |
| March 31, 2023 | -9.155M |
| December 31, 2022 | -9.157M |
| September 30, 2022 | -8.492M |
| Date | Value |
|---|---|
| June 30, 2022 | -7.610M |
| March 31, 2022 | -6.437M |
| December 31, 2021 | -4.855M |
| September 30, 2021 | -1.681M |
| June 30, 2021 | -1.703M |
| March 31, 2021 | -1.135M |
| December 31, 2020 | -0.548M |
| September 30, 2020 | -0.5993M |
| June 30, 2020 | -0.4991M |
| March 31, 2020 | -0.3889M |
| December 31, 2019 | -0.1403M |
| September 30, 2019 | -0.2109M |
| June 30, 2019 | -0.3769M |
| March 31, 2019 | -0.5577M |
| December 31, 2018 | -0.7486M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lexaria Bioscience Corp. | -7.527M |
| InMed Pharmaceuticals, Inc. | -8.628M |
| Target Group, Inc. (Canada) | -1.168M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -61.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.250M |
| Cash from Investing (Quarterly) | -0.1388M |
| Cash from Financing (Quarterly) | 4.138M |
| Free Cash Flow Per Share (Quarterly) | -2.097 |
| Free Cash Flow to Equity (Quarterly) | -3.378M |
| Free Cash Flow to Firm (Quarterly) | -3.393M |
| Free Cash Flow Yield | -373.5% |